Company news

Amplia Therapeutics Ltd. news in 2021

Amplia Therapeutics Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Amplia Provides Updated Investor Presentation

December 15, 2021

Entitlement Offer Completed

December 10, 2021

Amplia Awarded $2.1M R&D Cash Flow Loan

December 2, 2021

App 4D and Financial Report Half Year ended 30 Sep 2021

November 24, 2021

Inhibition of FAK by AMP945 in Phase 1 Clinical Trial

November 16, 2021

Capital Raising Investor Presentation

November 7, 2021

Entitlement Offer Prospectus

November 7, 2021

Placement and Underwritten Entitlement Offer to Raise $12.4m

November 7, 2021

Quarterly Activities and Cashflow Reports - Sep 2021 Qtr

October 27, 2021

Amplia Receives $1.1m R&D Tax Incentive

October 13, 2021

New Garvan Publication Supports Amplia Phase 2 Design

September 29, 2021

Phase 2 Trial in First-Line Pancreatic Cancer Patients

September 14, 2021

AGM - Chief Executive Officers Presentatioin

August 27, 2021

Quarterly Activities and Cashflow Reports and Presentation

July 27, 2021

Results from Successful Phase 1 Clinical Trial of AMP945

July 20, 2021

Amplia and Garvan Enter Into Collaboration Agreement

June 27, 2021

AMP945 Improves Survival in Pacnreatic Cancer Model

June 1, 2021

App 4E - Preliminary Final Report YE 31 March 2021

May 31, 2021

Proposed issue of Securities - ATX

May 4, 2021

Amplia Announces $3.8m Share Placement

May 3, 2021

Preclinical Data Support Developmnt AMP945 Pancreatic Cancer

April 27, 2021

Quarterly Report and Shareholder Update

April 27, 2021

ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH

April 19, 2021

Amplia Completes Dosing in Phase 1 Clinical Study of AMP945

April 14, 2021

Amplia and Garvan Institute Enter Collaboration Agreement

March 17, 2021

Amplia Completes Single Dose Study of AMP945

March 16, 2021

Amplia Initiates Multiple Dose Study of AMP945

February 16, 2021

Investor Update - February 2021

February 10, 2021

Quarterly Activities and Cashflow Reports - Dec 2020 Qtr

January 27, 2021

Decks in 2021